Principal Scientist, Translational Sciences (Oncology)
Other
1 views0 saves0 applied
Quick Summary
Overview
Repertoire Immune Medicines is a clinical-stage biotechnology company harnessing the power of the human immune system to develop transformative therapies for cancer and autoimmune disease.
Technical Tools
Other
Repertoire Immune Medicines is a clinical-stage biotechnology company harnessing the power of the human immune system to develop transformative therapies for cancer and autoimmune disease. Using its proprietary DECODETM platform—which maps the immune synapse between T cell receptors (TCRs) and their antigen targets—Repertoire translates unique biological insights into potent and targeted off-the-shelf immune medicines. The company integrates deep protein engineering expertise with artificial intelligence, powered by a proprietary DECODE database of over one billion TCR-antigen interactions, to accelerate discovery and optimize drug candidates.
From its sites in Watertown, Massachusetts and Zurich, Switzerland, Repertoire is advancing a pipeline of T cell-targeted immunotherapies with the potential to address a broad range of cancers and autoimmune disorders. The company’s lead oncology program, RPTR-1-201, a TCR bispecific, has initiated a Phase 1/2 clinical trial across multiple solid tumor indications. Repertoire plans to advance additional TCR bispecific therapies into clinical trials over the next 12-18 months. In autoimmune disease, Repertoire is partnering with leading pharmaceutical companies to develop mRNA tolerizing therapies designed to selectively expand regulatory T cells and reset the immune system.
Repertoire was founded in 2019 by Flagship Pioneering and is supported by a strong investor base. The DECODE platform has been validated through four strategic partnerships with leading pharmaceutical companies—Bristol Myers Squibb, Genentech, Eli Lilly, and Pfizer—representing over $4.5 billion in disclosed total deal value and $185 million in upfront payments received to date.
Role Overview
Recruitment & Staffing Agencies: Repertoire Immune Medicines (“Repertoire”) does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Repertoire or its employees is strictly prohibited unless contacted directly by Repertoire’s internal Human Resources team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Repertoire, and Repertoire will not owe any referral or other fees with respect thereto.
From its sites in Watertown, Massachusetts and Zurich, Switzerland, Repertoire is advancing a pipeline of T cell-targeted immunotherapies with the potential to address a broad range of cancers and autoimmune disorders. The company’s lead oncology program, RPTR-1-201, a TCR bispecific, has initiated a Phase 1/2 clinical trial across multiple solid tumor indications. Repertoire plans to advance additional TCR bispecific therapies into clinical trials over the next 12-18 months. In autoimmune disease, Repertoire is partnering with leading pharmaceutical companies to develop mRNA tolerizing therapies designed to selectively expand regulatory T cells and reset the immune system.
Repertoire was founded in 2019 by Flagship Pioneering and is supported by a strong investor base. The DECODE platform has been validated through four strategic partnerships with leading pharmaceutical companies—Bristol Myers Squibb, Genentech, Eli Lilly, and Pfizer—representing over $4.5 billion in disclosed total deal value and $185 million in upfront payments received to date.
Role Overview
We are seeking a highly motivated and experienced professional in Translational Sciences that will be responsible for developing, implementing, and executing cross-functional activities to bridge preclinical and clinical development programs, across multiple therapeutic areas and drug modalities. A successful candidate will have a deep knowledge and focus on protein therapeutics, immune-oncology drug development, and genomic capabilities.
Reporting to the Vice President, Project Lead and Head of Translational Medicine, this accomplished individual will have deep expertise in biomarkers in oncology to lead the design, implementation, and oversight of biomarker strategies for Phase I clinical trials in solid tumors. The ideal candidate will have a strong background in circulating tumor DNA (ctDNA), genomic profiling, and immune/DNA-based assays, as well as hands-on experience managing biomarker vendors and ensuring high-quality execution of exploratory biomarker analyses.
Compensation and Benefits
The base salary for this role ranges from $170,000 to $210,000 and is determined based on a candidate’s skills, experience, and internal equity. In addition to a competitive base salary, Repertoire offers a broad range of benefits designed to attract, retain, and motivate top talent, including medical, dental, vision, and life insurance, flexible time off, a 401(k) retirement plan, and short- and long-term incentive opportunities. Compensation and benefits are based on Repertoire’s good faith estimate at the time of publication and may be updated in the future.
Reporting to the Vice President, Project Lead and Head of Translational Medicine, this accomplished individual will have deep expertise in biomarkers in oncology to lead the design, implementation, and oversight of biomarker strategies for Phase I clinical trials in solid tumors. The ideal candidate will have a strong background in circulating tumor DNA (ctDNA), genomic profiling, and immune/DNA-based assays, as well as hands-on experience managing biomarker vendors and ensuring high-quality execution of exploratory biomarker analyses.
Key Responsibilities
- Design and execute translational biomarker strategies to support mechanism-of-action, PK/PD, dose predictions, and patient stratification in Phase I/II first-in-human oncology trials.
- Integrate preclinical and clinical data to generate hypotheses and guide data-driven decision-making in early development.
- Lead development and implementation of exploratory and translational biomarkers, including immune profiling, ctDNA, and genomic assays, with a strong understanding of solid tumor biology.
- Evaluate and oversee protein biomarker assays relevant to therapeutic response and resistance.
- Manage external vendors and CROs for biomarker assay development, sample testing, and data delivery; ensure high-quality execution and troubleshooting as needed.
- Oversee sample logistics (tumor tissue, liquid biopsies) to ensure integrity and timely analysis.
- Partner closely with Clinical Development and Discovery Research teams to ensure translational plans align with clinical objectives and regulatory strategies.
- Work closely with leadership to develop, manage, and deliver translational research timelines, budgets, metrics, and milestones.
- Demonstrate a strong work ethic and ability to work well in team environment.
- Communicate key findings and recommendations to senior leadership.
- PhD, MD, or equivalent in cancer biology, oncology, immunology, molecular biology, or related field.
- 8+ years of biotech/pharma experience in translational sciences or biomarker research, ideally in a biotech or pharmaceutical environment.
- Deep understanding of solid tumor biology, immune biomarkers, and ctDNA/genomic analysis, along with hands-on experience managing biomarker execution in early-phase clinical trials.
- Strong understanding of drug development for protein therapeutics and immune-oncology mechanisms.
- Demonstrated experience supporting Phase I/II first-in-patient clinical studies.
- Experience incorporating ctDNA endpoints into Phase I/II oncology clinical trials, including exploratory biomarker strategies and regulatory considerations.
- Experience transferring and overseeing assays at CROs or central labs.
- Working knowledge of pharmacokinetics (PK) and anti-drug antibody (ADA) assessments for protein therapeutics, and ability to integrate PK/ADA findings with biomarker and clinical data to guide early development decisions.
- Hands-on or oversight experience with circulating tumor DNA (ctDNA), including use in solid tumor clinical trials for patient stratification and treatment response monitoring.
- Entrepreneurial mindset, excellent communication skills, and passion for advancing new therapies for patients.
Compensation and Benefits
The base salary for this role ranges from $170,000 to $210,000 and is determined based on a candidate’s skills, experience, and internal equity. In addition to a competitive base salary, Repertoire offers a broad range of benefits designed to attract, retain, and motivate top talent, including medical, dental, vision, and life insurance, flexible time off, a 401(k) retirement plan, and short- and long-term incentive opportunities. Compensation and benefits are based on Repertoire’s good faith estimate at the time of publication and may be updated in the future.
Repertoire is committed towards social responsibility and developing an inclusive culture. Much as the power of the immune system lies in the diversity of T and B cells, our work requires the creativity and ingenuity of a diverse workforce. We believe in actively pursuing equity in all facets of the work experience at Repertoire. We will continue to educate ourselves about the inequities and barriers present in our society and take action as a company where we can make a difference. Repertoire is proud to be an Equal Opportunity Employer. |
Recruitment & Staffing Agencies: Repertoire Immune Medicines (“Repertoire”) does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Repertoire or its employees is strictly prohibited unless contacted directly by Repertoire’s internal Human Resources team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Repertoire, and Repertoire will not owe any referral or other fees with respect thereto.
Location & Eligibility
Where is the job
Watertown, United States
On-site at the office
Who can apply
US
About this job
- Pay per year
- $170,000–$210,000 a year
- 182% above the $67,361 median for Other jobs on Jobera (148,287 salaries).
- Who can apply
- United States
- Posted
- 1 day ago
Listing Details
- Posted
- November 17, 2026
- First seen
- November 17, 2026
- Last seen
- November 18, 2026
Posting Health
- Days active
- 0
- Repost count
- 0
- Trust Level
- 68%
- Scored at
- November 18, 2026
Signal breakdown
freshnesssource trustcontent trustemployer trust
Newsletter
Stay ahead of the market
Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.
A
B
C
D
No spam. Unsubscribe at any time.